Vestmark Advisory Solutions’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
4,325
+1,116
+35% +$414K 0.02% 782
2026
Q1
$940K Sell
3,209
-1,319
-29% -$434K 0.01% 892
2025
Q4
$1.59M Buy
4,528
+1,157
+34% +$391K 0.02% 658
2025
Q3
$1.09M Buy
3,371
+1,494
+80% +$465K 0.02% 524
2025
Q2
$730K Buy
+1,877
New +$755K 0.01% 555
2023
Q3
Sell
-7,447
Closed -$3.31M 547
2023
Q2
$3.31M Buy
7,447
+496
+7% +$229K 0.13% 210
2023
Q1
$3.2M Buy
6,951
+1,078
+18% +$513K 0.14% 199
2022
Q4
$3.01M Sell
5,873
-103
-2% -$52.3K 0.15% 193
2022
Q3
$2.71M Buy
5,976
+1,215
+26% +$581K 0.15% 190
2022
Q2
$2.3M Sell
4,761
-51
-1% -$25.2K 0.13% 208
2022
Q1
$2.36M Buy
4,812
+2,976
+162% +$1.36M 0.13% 204
2021
Q4
$851K Buy
1,836
+58
+3% +$24.4K 0.05% 399
2021
Q3
$663K Buy
1,778
+305
+21% +$116K 0.04% 415
2021
Q2
$562K Buy
1,473
+71
+5% +$27.1K 0.04% 445
2021
Q1
$503K Sell
1,402
-42
-3% -$13.5K 0.04% 439
2020
Q4
$464K Sell
1,444
-258
-15% -$79.2K 0.05% 373
2020
Q3
$457K Sell
1,702
-215
-11% -$57.9K 0.06% 339
2020
Q2
$504K Buy
1,917
+97
+5% +$25.9K 0.08% 302
2020
Q1
$413K Buy
+1,820
New +$496K 0.08% 296
2019
Q4
Sell
-1,484
Closed -$356K 336
2019
Q3
$356K Sell
1,484
-77
-5% -$21.1K 0.06% 372
2019
Q2
$441K Buy
1,561
+99
+7% +$27K 0.08% 308
2019
Q1
$420K Buy
+1,462
New +$423K 0.07% 315

Other funds holding ELV

Vestmark Advisory Solutions's ELV Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Elevance Health (ELV) stake by 35% in Q2 2026, buying an estimated $414K and bringing the position to 4,325 shares worth $1.67M. The position accounts for 0.02% of the portfolio, ranked #782.

Vestmark Advisory Solutions first reported a position in ELV in Q1 2019 and has held it in 22 quarters since. The position peaked at $3.31M in Q2 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Vestmark Advisory Solutions held 4,325 shares of Elevance Health worth $1.67M as of Q2 2026.
  • Vestmark Advisory Solutions bought 1,116 Elevance Health shares in Q2 2026, an estimated $414K.
  • Elevance Health made up 0.02% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #782 holding.
  • Vestmark Advisory Solutions first reported a position in Elevance Health in Q1 2019 and has held it in 22 quarters since.
  • Vestmark Advisory Solutions's Elevance Health position peaked at $3.31M in Q2 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.